
Kopran Ltd Technical Momentum Shifts Amid Mixed Market Signals
2026-05-21 08:01:57Kopran Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a sideways trend. Despite a recent downgrade in daily moving averages and a 2.93% decline in the stock price, several weekly and monthly technical indicators present a complex picture of the stock’s near-term prospects.
Read MoreAre Kopran Ltd latest results good or bad?
2026-05-20 19:22:52Kopran Ltd's latest financial results for the quarter ended March 2026 reflect a notable recovery from previous periods, showcasing significant improvements across key metrics. The company reported net sales of ₹234.02 crores, representing a year-on-year growth of 35.77% compared to ₹172.36 crores in the same quarter last year. This growth indicates a robust demand recovery in the pharmaceutical formulations and API segments. The net profit for the quarter reached ₹18.87 crores, marking a substantial year-on-year increase of 94.94% from ₹9.68 crores in Q4 FY25. This recovery is particularly striking when considering the company's performance in the preceding September 2025 quarter, where it recorded a net loss of ₹9.92 crores. The operating profit margin also improved significantly, reaching 14.08%, which is the highest margin reported in at least eight quarters, up from 9.91% in the same quarter last year...
Read More
Kopran Ltd Technical Momentum Shifts Signal Mildly Bullish Outlook
2026-05-20 08:02:23Kopran Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable shift in its technical momentum, moving from a mildly bearish to a mildly bullish trend. This change is underscored by a 4.43% gain in the stock price on 20 May 2026, closing at ₹172.25, signalling renewed investor interest amid broader market volatility.
Read More
Kopran Ltd Reports Strong Quarterly Turnaround with Robust Revenue and Margin Gains
2026-05-20 08:00:14Kopran Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has demonstrated a notable financial turnaround in the quarter ended March 2026, shifting from a negative to a positive growth trajectory. The company’s latest quarterly results reveal record highs in revenue, profitability, and operating efficiency, signalling a potential inflection point after a period of subdued performance.
Read More
Kopran Ltd is Rated Sell by MarketsMOJO
2026-05-11 10:11:13Kopran Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 07 Apr 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 11 May 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and technical outlook.
Read MoreWhen is the next results date for Kopran Ltd?
2026-05-07 23:16:57The next results date for Kopran Ltd is scheduled for 19 May 2026....
Read More
Kopran Ltd is Rated Sell by MarketsMOJO
2026-04-30 10:11:00Kopran Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 07 Apr 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 30 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.
Read More
Kopran Ltd is Rated Sell by MarketsMOJO
2026-04-19 10:10:37Kopran Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 07 April 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 19 April 2026, providing investors with an up-to-date view of the company's fundamentals, returns, and market performance.
Read MoreKopran Ltd Gains 25.43%: Technical Momentum Shift Amid Persistent Financial Challenges
2026-04-11 17:02:12Key Events This Week 6 Apr: Week opens at Rs.125.25 7 Apr: Rating upgraded to Sell; stock jumps 7.43% 8 Apr: Technical momentum shift; intraday high Rs.144.20 9 Apr: Continued gains with 6.88% rise to Rs.156.20 10 Apr: Week closes at Rs.157.10, up 0.58% on day Week OpenRs.125.25 W...
Read MoreShareholder Meeting / Postal Ballot-Outcome of Court Convened Meeting
04-Jun-2026 | Source : BSEOutcome of NCLT convened meeting for equity shareholders secured creditor and unsecured creditor held on 03.06.2026
Compliances-Reg.24(A)-Annual Secretarial Compliance
22-May-2026 | Source : BSEAnnual Secretarial Compliance Report for the year ended March 31 2026
Announcement under Regulation 30 (LODR)-Newspaper Publication
21-May-2026 | Source : BSENewspaper Advertisement for the Q4 Results FY 2025-26
Corporate Actions
No Upcoming Board Meetings
Kopran Ltd has declared 30% dividend, ex-date: 04 Sep 25
No Splits history available
No Bonus history available
No Rights history available